Company Biography
An Assessment of Extended Pembrolizumab Dosing and Outcomes in Advanced Non-Small Cell Lung Cancer Patients During the COVID-19 Pandemic
Link to Abstract. A PDF of the poster is available to download under the Resources tab
Contact Information
Name
Gordon Taylor Moffat
You have chosen to your
information with
An Assessment of Extended Pembrolizumab Dosing and Outcomes in Advanced Non-Small Cell Lung Cancer Patients During the COVID-19 Pandemic
Team Members
Gordon Moffat, MD, FRCPC
Queen's University
Medical Oncology Fellow
Lilian Hanna, DO
Queen's University
Medical Oncology Fellow
Wilma Hopman, MA
Queen's University
Research Methodologist
Andrea S. Fung, MD, PhD, FRCPC
Queen's University
Medical Oncologist